ATC level 4
B02BDMedicines that stop bleeding, subgroup B02B, subgroup B02BD
- Molecules
- 25
- Subgroups
- 11
ATC B02BD (Medicines that stop bleeding, subgroup B02B, subgroup B02BD) is a level 4 group in the anatomical therapeutic chemical classification. The catalogue lists 25 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
- B02BD02Efmoroctocog alfa10
- B02BD04Eftrenonacog alfa5
- B02BD05Eptacog alfa1
- B02BD06Human coagulation factor viii and Human von willebrand factor1
- B02BD08Eptacog beta2
- B02BD09Nonacog alfa2
- B02BD10Vonicog alfa1
- B02BD11Catridecacog1
- B02BD13Human coagulation factor x1
- B02BD14Susoctocog alfa1
- B02BD15Valoctocogene roxaparvovec1
Molecules
Molecules with an ATC code under B02BD.
- Albutrepenonacog alfaOrphan1 brandB02BD04
- Catridecacog1 brandB02BD11
- Coagulation factor ix recombinant humanBiologic1 presentation1 brandB02BD09
- Damoctocog alfa pegol1 brandB02BD02
- Efanesoctocog alfaOrphan1 brandB02BD02
- Efmoroctocog alfa1 brandB02BD02
- Eftrenonacog alfaOrphan1 brandB02BD04
- Eptacog alfa1 brandB02BD05
- Eptacog beta1 brandB02BD08
- Etranacogene dezaparvovecOrphan1 presentation1 brandB02BD
- Human coagulation factor viii and Human von willebrand factor1 brandB02BD06
- Human coagulation factor xOrphan1 brandB02BD13
- Lonoctocog alfa1 brandB02BD02
- Moroctocog alfa1 brandB02BD02
- Nonacog alfa1 brandB02BD04
- Nonacog beta pegol1 brandB02BD04
- Nonacog gamma1 brandB02BD04
- Octocog alfa2 brandsB02BD02
- Rurioctocog alfa pegol1 brandB02BD02
- Simoctocog alfa2 brandsB02BD02
- Susoctocog alfa1 brandB02BD14
- Turoctocog alfa1 brandB02BD02
- Turoctocog alfa pegol1 brandB02BD02
- Valoctocogene roxaparvovecOrphan1 brandB02BD15
- Vonicog alfa1 brandB02BD10
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.